Patent details

EP1897555 Title: Supplemented OMV vaccine against meningococcus

Basic Information

Publication number:
EP1897555
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP070134531
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Supplemented OMV vaccine against meningococcus
French Title of Invention:
Vaccin OMV complété contre la méningocoque
German Title of Invention:
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
SPC Number:

Dates

Filing date:
17/01/2001
Grant date:
16/07/2014
EP Publication Date:
16/07/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/03/2008
EP B1 Publication Date:
16/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/01/2018
Expiration date:
17/01/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/2018
 
 

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:
17/01/2001
To:
09/03/2018

Name:
Novartis Vaccines and Diagnostics S.r.l.
Address:
Via Fiorentina 1, 53100 Siena (SI), Italy (IT)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/09/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Pizza Mariagrazia
Address:
Italy (IT)

2

Name:
Giuliani Marzia
Address:
Italy (IT)

3

Name:
Rappuoli Rino
Address:
Italy (IT)

Priority

1

Priority Number:
0001067
Priority Date:
17/01/2000
Priority Country:
United Kingdom (GB)

2

Priority Number:
0005699
Priority Date:
09/03/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/095;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/05
Publication date:
11/04/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000090A
Date Registered:
09/03/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK (Luxembourg) LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
17/01/2017
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
31/05/2018 Outgoing Correspondence 1
09/03/2018 Request For Change 9
09/03/2018 Outgoing Correspondence 1